Clayton Partners’s IRIDEX IRIX Stock Holding History

Clayton Partners’s Portfolio IRIX Stock Details IRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,793	Closed	-$58.5K	–	36
2023 Q1	$58.5K	Buy	+28,793	New	+$63.7K	0.06%	32

Other funds holding IRIX

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Clayton Partners's IRIX Position: Q2 2023 in Review

Clayton Partners sold out of IRIDEX (IRIX) in Q2 2023, closing a stake of 28,793 shares — an estimated $58.5K sold.

Clayton Partners first reported a position in IRIX in Q1 2023 and held it in 1 quarter. The position peaked at $58.5K in Q1 2023. 28 funds tracked by Wall St. Rank hold IRIX as of Q2 2023.

Clayton Partners reported no remaining IRIDEX position as of Q2 2023 after selling out during the quarter.
Clayton Partners sold 28,793 IRIDEX shares in Q2 2023, an estimated $58.5K.
Clayton Partners first reported a position in IRIDEX in Q1 2023 and held it in 1 quarter.
Clayton Partners's IRIDEX position peaked at $58.5K in Q1 2023.
28 funds tracked by Wall St. Rank held IRIDEX as of Q2 2023.

Based on Clayton Partners's 13F filing for Q2 2023, filed 14 Aug 2023.